FT ACID REDUCER-ANTACID TB CHW

famotidine, calcium carbonate and magnesium hydroxide
$0.2595per EA
OTC

Strength

800; 10; 165 mg/1; mg/1; mg/1

NDC

70677110001

Classification

Generic

Dosage Form

TABLET, CHEWABLE

Route

ORAL

Last Updated

4/22/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA077355

On Market Since

10/31/2023

Pharmacological Classes

Calculi Dissolution Agent
Histamine H2 Receptor Antagonists
Histamine-2 Receptor Antagonist
Increased Large Intestinal Motility
Inhibition Large Intestine Fluid/Electrolyte Absorption
Inhibition Small Intestine Fluid/Electrolyte Absorption
Magnesium Ion Exchange Activity
Osmotic Activity
Osmotic Laxative
Stimulation Large Intestine Fluid/Electrolyte Secretion

Price History

1W

0.0%

1M

+0.9%

3M

+0.9%

6M

-0.0%

1Y

+0.2%

3Y

N/A

5Y

N/A

All

+8.0%